Does too much sharing joepardize clinical trials?

Options

Comments

  • vlnrph
    vlnrph Member Posts: 1,632
    edited July 2014

    Excellent analysis and worrisome results: I can see how the FDA might delay approval if studies are compromised by too much data sharing/communication.

    While on-line support is very helpful, everyone should recognize the dangers of overexposing their personal health information. Some things are better left confidential. Consent forms probably do need to specify limits on blog posting, etc.

Categories